KVUE stock price: Kenvue soars 19% today, Kimberly-Clark deal offers a win after Trump Tylenol drama

The announcement comes just weeks after President Trump publicly spread debunked claims that Tylenol consumption is linked to autism.

Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega-deal

Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer product conglomerate.

Tylenol trust crisis: Trump, RFK Jr. and Texas lawsuits slam Kenvue

Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when the Republican state of Texas sued them. The complaint says that the ...

Kenvue stock share price today: Kimberly-Clark to acquire Tylenol maker Kenvue for $40 billion in cash and stock deal. Here's background, current challenges, future out…

Kenvue stock share price today shows a major surge after Kimberly-Clark announced plans to buy Kenvue for over $40 billion.

Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks?

Even though Kenvue's stock was already in a tailspin before the FDA warned pregnant woman that Tylenol posed a health risk, ...

Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...